Does the presence of secondary antiphospholipid syndrome in patients with systemic lupus erythematodes accelerate carotid arteries intima-media thickness changes?

Rheumatology International

Volumn 34, Issue 3, 2014, Pages 321-327

  Djokovic, Aleksandra ^a   Stojanovich, Lj ^a   Stanisavljevic, N ^a   Bisenic, V ^a   Radovanovic, S ^a   Soldatovic, I ^c   Simic, D V ^b  

^a Medical Center Bezanijska Kosa   (Serbia)

^b CLINICAL CENTER OF SERBIA   (Serbia)

^c UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Antiphospholipid syndrome; Carotid intima media thickness; Systemic lupus erythematosus

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHOLIPID ANTIBODY; PREDNISONE; TRIACYLGLYCEROL;

ADULT; AGE; ANTIPHOSPHOLIPID SYNDROME; ARTERIAL WALL THICKNESS; ARTERY THROMBOSIS; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CAROTID ARTERY; CAROTID ARTERY INTIMA MEDIA THICKNESS; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT; COMMON CAROTID ARTERY; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DIET RESTRICTION; DISEASE DURATION; DISEASE MARKER; DOPPLER FLOWMETRY; FEMALE; GENDER; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; INTERNAL CAROTID ARTERY; MAJOR CLINICAL STUDY; MALE; MENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; SECONDARY ANTIPHOSPHOLIPID SYNDROME; SLEDAI; SYSTEMIC LUPUS ERYTHEMATOSUS; TRIACYLGLYCEROL BLOOD LEVEL; VEIN THROMBOSIS;

ADULT; ANTIPHOSPHOLIPID SYNDROME; CAROTID ARTERIES; CAROTID ARTERY DISEASES; CAROTID INTIMA-MEDIA THICKNESS; CASE-CONTROL STUDIES; COMORBIDITY; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RISK FACTORS;

EID: 84896740156     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-013-2903-0     Document Type: Article

References (31)

1. Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M (2007) Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 115(4):459-467
2. Costanzo P, Perrone-Filardi P, Vassallo E et al (2010) Does carotid intima-media thickness regression predict reduction of cardiovascular events? A meta-analysis of 41 randomized trials. J Am Coll Cardiol 56(24):2006-2020
3. Cervera R, Khamashta MA, Font J et al (2003) Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore) 82(5):299-308
4. Lopez LR, Salazar-Paramo M, Palafox-Sanchez C, Hurley BL, Matsura E, Garcia-De La Torre I (2006) Oxidized low-density lipoprotein and β2-glycoprotein I in patients with systemic lupus erythematosus and increased carotid intima-media thickness: implications in autoimmune-mediated atherosclerosis. Lupus 15:80-86
5. Jimenez S, Garcia-Criado MA, Tassies D et al (2005) Preclinical vascular disease in systemic lupus erythematosus and primary antiphospholipid syndrome. Rheumatology 44:756-761
6. Soltesz P, Der H, Veres K, Laczik R et al (2008) Immunological features of primary anti-phospholipid syndrome in connection with endothelial dysfunction. Rheumatology 47:1628-1634
7. Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725
8. Bombardieri C, Gladman DD, Urowitz MB et al (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The committee on prognosis studies in SLE. Arthritis Rheum 35:630-640
9. Miyakis S, Lockshin MD, Atsumi T et al (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4:295-306
10. Hypertension PickeringG (1972) Definitions, natural histories and consequences. Am J Med 52:570-583
11. Ruiz-Irastorza G, Crowther M, Branch W, Khamashta MA (2010) Antiphospholipid syndrome. Lancet 376:1498-1509
12. Pengo V, Biasolo A, Pegoraro C, Cucchini U, Noventa F, Iliceto S (2005) Antibody profiles for the diagnosis of antiphospholipid syndrome. Thromb Haemost 93(6):1147-1152
13. Brandt JT, Triplett DA, Alving B, Scharrer I (1995) Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH. Thromb Haemost 74:1185-1190
14. Stein JH, Korcarz CE, Hurst RT et al (2008) American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force Endorsed by the Society for Vascular Medicine. J Am Soc Echocardiogr 21(2):93-111
15. Lorenz MW, Polak JF, Kavousi M et al (2012) PROG-IMT Study Group. Carotid intima-media thickness progression to predict cardiovascular events in the general population (the PROG-IMT collaborative project): a meta-analysis of individual participant data. Lancet 379(9831):2053-2062
16. Urowitz MB, Bookman AA, Koehler BE, Gordon DA, Smythe HA, Ogryzlo MA (1976) The bimodal mortality pattern of systemic lupus erythematosus. Am J Med 60:21-25
17. Doria A, Shoenfeld Y, Wu R et al (2003) Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus. Ann Rheum Dis 62:1071-1077
18. Zhang CY, Lu LJ, Li FH et al (2009) Evaluation of risk factors that contribute to high prevalence of premature atherosclerosis in Chinese premenopausal systemic lupus erythematosus patients. J Clin Rheumatol 15(3):111-116
19. Der H, Kerekes G, Veres K et al (2007) Impaired endothelial function and increased carotid intima-media thickness in association with elevated von Willebrand antigen level in primary antiphospholipid syndrome. Lupus 16(7):497-503
20. Ames PR, Margarita A, Alves JD (2009) Antiphospholipid antibodies and atherosclerosis: insights from systemic lupus erythematosus and primary antiphospholipid syndrome. Clin Rev Allergy Immunol 37(1):29-35
21. Matsuura E, Lopez LR, Shoenfeld Y, Ames PR (2012) β2-glycoprotein I and oxidative inflammation in early atherogenesis: a progression from innate to adaptive immunity? Autoimmun Rev 12(2):241-249
22. Libby P (2008) Role of inflammation in atherosclerosis associated with rheumatoid arthritis. Am J Med 121:21-31
23. Vlachoyiannopoulos PG, Kanellopoulos PG, Ioannidis JP, Tektonidou MG, Mastorakou I, Moutsopoulos HM (2003) Atherosclerosis in premenopausal women with antiphospholipid syndrome and systemic lupus erythematosus: a controlled study. Rheumatology (Oxford) 42(5):645-651
24. de Leeuw K, Smit AJ, de Groot E, van Roon AM, Kallenberg CG, Bijl M (2009) Longitudinal study on premature atherosclerosis in patients with systemic lupus erythematosus. Atherosclerosis 206(2):546-550
25. Lockshin M, Tenedios F, Petri M et al (2003) Cardiac disease in the antiphospholipid syndrome: recommendations for treatment Committee consensus report. Lupus 12(7):518-523
26. Salmon JE, Roman MJ (2008) Subclinical atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus. Am J Med 121(10 Suppl 1):S3-S8
27. Bilora F, Sartori MT, Zanon E, Campagnolo E, Arzenton M, Rossato A (2009) Flow-mediated arterial dilation in primary antiphospholipid syndrome. Angiology 60(1):104-107
28. Damoiseaux J, Jeyasekharan AD, Theunissen R, Tervaert JW (2005) Cross reactivity of IgM and IgG anticardiolipin antibodies with oxidized-low density lipoproteins. Ann N Acad Sci 1050:163-169
29. Artenjak A, Lakota K, Frank M et al (2012) Antiphospholipid antibodies as non-traditional risk factors in atherosclerosis based cardiovascular diseases without overt autoimmunity. A critical updated review. Autoimmun Rev 11(12):873-882
30. Ames PR, Margarita A, Delgado Alves J, Tommasino C, Iannaccone L, Brancaccio V (2002) Anticardiolipin antibodies independently predict intima/media thickness of carotid arteries in subjects with idiopathic antiphospholipid antibodies. Lupus 11:208-214
31. Rose NR, Bona C (1993) Defining criteria for autoimmune diseases (Witebsky's postulates revisited). Immunol Today 14(9):426-430